Concentrix Corporation
NASDAQ:CNXCInformation Technology Services
-$0.75 today
- Market cap
- $1.87B
- Beta
- 0.42
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$21.66
- Dividend yield
- 5.73%
Volume 0.74M
Average 1.64M
CNXC EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Concentrix CorporationNASDAQ: CNXC
EBITDA · Q1 FY2026 · quarter ended Feb 2026
EBITDA declines year over year
Q1 FY2026 EBITDA of $263.42M fell 21.3% year over year, ahead of the -123.1% change in trailing-twelve-month EBITDA.
Context
- EBITDA amounted to 2.5% of revenue in FY2025, down 11.3 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $1.7B (+805.1%) for the fiscal year ending Nov 2026, a step up from the -118.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterFeb 2026
- $263.42M+121.7% QoQ
- Last fiscal yearNov 2025
- -$241.77M-118.2% YoY
- LTMFeb 2026
- -$305.24M-123.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -21.3% | -4.8% | +16.4 pp |
| 1 year | -118.2% | +805.1% | +923.3 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (241.77M) USD
- Year-over-year change
- -118.2%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-11-30 | (241.77M) | -118.2% |
| FY2024 | 2024-11-30 | 1.33B | +33.0% |
| FY2023 | 2023-11-30 | 997.53M | +1.3% |
| FY2022 | 2022-11-30 | 984.62M | +15.0% |
| FY2021 | 2021-11-30 | 855.92M | — |
EBITDA vs competitors
How CNXC compares with its peers on the latest reported figures
- CNXC's LTM Feb 2026 EBITDA of -$305.24M is the lowest of the 9 companies compared; the peer median is $72.1M.
- Its year-over-year change of -123.1% is the lowest of 9, against a peer median of +29.6%.
- EBITDA amounts to 3.1% of revenue for CNXC, versus a peer median of 12.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $929.1M | +92.2% | — | 38.0% | |
| LTM Sep 2026 | $739.45M | +13.8% | +1.2% | 13.1% | |
| LTM Jun 2026 | $441.01M | +12.1% | +12.4% | 19.7% | |
| LTM Mar 2026 | $76.13M | +14.9% | +18.7% | 12.1% | |
| LTM Apr 2026 | $68.06M | +61.2% | — | 7.8% | |
| LTM Jun 2026 | $67.81M | +44.4% | — | 21.4% | |
| LTM Mar 2026 | $32.19M | +9.5% | — | 7.7% | |
| LTM Mar 2026 | -$22.92M | +52.5% | — | 1.1% | |
| LTM Feb 2026 | -$305.24M | -123.1% | — | 3.1% | |
| Peer median (excluding CNXC) | $72.1M | +29.6% | +12.4% | 12.6% | |
Competitors are the stored peer set for CNXC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Nov 2021 | FY2022 Nov 2022 | FY2023 Nov 2023 | FY2024 Nov 2024 | FY2025 Nov 2025 |
|---|---|---|---|---|---|
| Revenue | 5.59B | 6.32B | 7.11B | 9.62B | 9.83B |
| Cost of Revenue | 3.62B | 4.07B | 4.54B | 6.17B | 6.39B |
| Gross Profit | 1.97B | 2.26B | 2.58B | 3.45B | 3.44B |
| Gross Margin | 35.3% | 35.7% | 36.2% | 35.9% | 35.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.4B | 1.62B | 1.92B | 2.85B | 2.83B |
| Operating Expenses | 1.4B | 1.62B | 1.92B | 2.85B | 2.83B |
| Depreciation & Amortization | 277.18M | 309.54M | 388.3M | 705.85M | 650.11M |
| EBITDA | 855.92M | 984.62M | 997.53M | 1.33B | (241.77M) |
| EBITDA Margin | 15.3% | 15.6% | 14.0% | 13.8% | -2.5% |
| Operating Income | 572.4M | 640.19M | 661.33M | 596.39M | 609.54M |
| Operating Margin | 10.2% | 10.1% | 9.3% | 6.2% | 6.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 23.05M | 70.08M | 201M | 321.83M | 290.35M |
| Other Income / Expenses | (16.7M) | (35.19M) | (253.1M) | (297.11M) | (1.79B) |
| Income Before Tax | 555.7M | 605M | 408.23M | 299.27M | (1.18B) |
| Pre-Tax Margin | 9.9% | 9.6% | 5.7% | 3.1% | -12.0% |
| Income Tax Expense | 150.12M | 169.36M | 94.39M | 48.06M | 96.7M |
| Net Income | 405.58M | 435.05M | 313.84M | 251.22M | (1.28B) |
| Net Margin | 7.3% | 6.9% | 4.4% | 2.6% | -13.0% |
| EPS (Basic) | 7.78 | 8.34 | 5.72 | 3.72 | (20.36) |
| EPS (Diluted) | 7.70 | 8.28 | 5.70 | 3.71 | (20.36) |
| Weighted Avg Shares | 51.36M | 51.35M | 53.8M | 64.98M | 63.01M |
| Weighted Avg Shares (Diluted) | 51.91M | 51.74M | 54.01M | 65.07M | 63.01M |
Concentrix Corporation
NASDAQ:CNXC
Intrinsic Alpha fair value
Locked
Current Price
$30.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.